AI companies using agentic healthcare models are lobbying federal officials to create a national licensing framework.
Developers say a single federal pathway would let advanced AI tools operate nationwide without navigating different rules in every state. According to reporting by Inside Health Policy (IHP), state‑by‑state approval slows innovation